469 related articles for article (PubMed ID: 17941006)
1. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
[TBL] [Abstract][Full Text] [Related]
2. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.
Koh ES; Tran TH; Heydarian M; Sachs RK; Tsang RW; Brenner DJ; Pintilie M; Xu T; Chung J; Paul N; Hodgson DC
Radiat Oncol; 2007 Mar; 2():13. PubMed ID: 17362522
[TBL] [Abstract][Full Text] [Related]
3. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
[TBL] [Abstract][Full Text] [Related]
4. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.
Johansen S; Danielsen T; Olsen DR
Acta Oncol; 2008; 47(3):391-6. PubMed ID: 18348001
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
6. Calculated risk of breast cancer following mantle irradiation determined by measured dose.
Janjan NA; Zellmer DL
Cancer Detect Prev; 1992; 16(5-6):273-82. PubMed ID: 1473117
[TBL] [Abstract][Full Text] [Related]
7. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks.
Shuryak I; Sachs RK; Hlatky L; Little MP; Hahnfeldt P; Brenner DJ
J Natl Cancer Inst; 2006 Dec; 98(24):1794-806. PubMed ID: 17179481
[TBL] [Abstract][Full Text] [Related]
9. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma.
Mazonakis M; Lyraraki E; Damilakis J
Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609
[TBL] [Abstract][Full Text] [Related]
10. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks.
Murray L; Sethugavalar B; Robertshaw H; Bayman E; Thomas E; Gilson D; Prestwich RJ
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):401-10. PubMed ID: 25840609
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.
Nieder C; Schill S; Kneschaurek P; Molls M
Radiother Oncol; 2007 Mar; 82(3):301-7. PubMed ID: 17156873
[TBL] [Abstract][Full Text] [Related]
13. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.
Johansen S; Cozzi L; Olsen DR
Acta Oncol; 2009; 48(4):495-503. PubMed ID: 19169915
[TBL] [Abstract][Full Text] [Related]
14. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
15. Malignant breast tumors after radiotherapy for a first cancer during childhood.
Guibout C; Adjadj E; Rubino C; Shamsaldin A; Grimaud E; Hawkins M; Mathieu MC; Oberlin O; Zucker JM; Panis X; Lagrange JL; Daly-Schveitzer N; Chavaudra J; de Vathaire F
J Clin Oncol; 2005 Jan; 23(1):197-204. PubMed ID: 15625374
[TBL] [Abstract][Full Text] [Related]
16. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
[TBL] [Abstract][Full Text] [Related]
17. Phantom measurements and computed estimates of breast dose with radiotherapy for Hodgkin's lymphoma: dose reduction with the use of the involved field.
Wirth A; Kron T; Wittwer H; Sullivan K; Sorell G; Cramb J
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):394-402. PubMed ID: 18811765
[TBL] [Abstract][Full Text] [Related]
18. Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?
Chen J; Lee RJ; Tsodikov A; Smith L; Gaffney DK
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1474-9. PubMed ID: 15050326
[TBL] [Abstract][Full Text] [Related]
19. Incidence of primary malignancies other than breast cancer among women treated with radiation therapy for benign breast disease.
Mattsson A; Hall P; Rudén BI; Rutqvist LE
Radiat Res; 1997 Aug; 148(2):152-60. PubMed ID: 9254734
[TBL] [Abstract][Full Text] [Related]
20. Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma.
Zwahlen DR; Martin JM; Millar JL; Schneider U
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):853-8. PubMed ID: 18164856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
